The Joint Committee on Vaccination and Immunisation (JCVI) advises UK health departments on immunisation. In 2013, after considering whether a vaccination should be introduced to protect children against MenB, the JCVI expressed concerns that the rules about which vaccines to fund are unfair towards vaccines that prevent severe, fatal and rare disease, and particularly in children.
A working group on Cost Effectiveness Methodology for Immunisation Policy and Procurement (CEMIPP) was set up to address the issues, and after persistent campaigning from MRF, a report from CEMIPP was finally published in February 2018 and organisations such as MRF were able to consult and provide feedback.
MRF wrote to the minister in charge of public health, on 18 February 2019 to ask for an update on progress in responding to this consultation.
Linda continued, “We encourage all parents to take up the offer of the vaccines that are included in the routine immunisation schedule for children to prevent some types of meningitis and septicaemia. However, there are not yet vaccines available to prevent all forms of the disease so it is vital that people are aware of the symptoms.”
See the routine immunisation schedule for children in the UK